Share on StockTwits

EvogeneLtd. (NASDAQ:EVGN) announced its earnings results on Wednesday. The company reported ($0.22) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.11) by $0.11, Analyst Ratings News reports. The company had revenue of $7.71 million for the quarter, compared to the consensus estimate of $4.66 million.

Shares of EvogeneLtd. (NASDAQ:EVGN) opened at 13.01 on Wednesday. EvogeneLtd. has a 52-week low of $5.75 and a 52-week high of $20.39. The stock has a 50-day moving average of $14. and a 200-day moving average of $16.97. The company’s market cap is $325.1 million.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.